Outlook Therapeutics (OTLK) Q4 2025 Earnings

19DecConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.89
-0.61
-0.34
-0.06

Details

Expected EPS
-0.26
Actual EPS
-0.06
Surprise EPS
0.2
Surprise Percent
+76.92%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.06 per share for Q4 2025.

0 Comments

Share your thoughts